Who
Michael Goldberg
Director
Company insider
Files Form 4 as: Director, CareDx; Director, eHealth.
In numbers
- Trades disclosed
- 180
- Buys
- 2
- Sells
- 24
- Bought
- $482K
- Sold
- $17.8M
- Companies
- 2
- Companies where not an officer
- 2
- First trade
- 6 Jun 2007
- Last trade
- 2 Oct 2026
- Last filed
- 5 Oct 2026
Companies traded
Activity over time
1 Nov 2024 – 1 Oct 2026
Buys above the line, sells below, each month.
Every trade
| Traded | Company | What | Amount | |
|---|---|---|---|---|
| 2 Oct 2026filed 5 Oct 2026 | CDNA CareDxDiagnostics & Labs | SEC FORM 4 Code A | —588 at $0.00 | filing |
| 4 Aug 2026filed 6 Aug 2026 | CDNA CareDxDiagnostics & Labs | SEC FORM 4 Sold | $2.1M44,700 at $47.06 | filing |
| 4 Aug 2026filed 6 Aug 2026 | CDNA CareDxDiagnostics & Labs | SEC FORM 4 Sold | $2.1M44,700 at $47.06 | filing |
| 2 Jul 2026filed 7 Jul 2026 | CDNA CareDxDiagnostics & Labs | SEC FORM 4 Code A | —1,746 at $0.00 | filing |
| 2 Jul 2026filed 7 Jul 2026 | CDNA CareDxDiagnostics & Labs | SEC FORM 4 Code A | —1,746 at $0.00 | filing |
| 12 Jun 2026filed 16 Jun 2026 | CDNA CareDxDiagnostics & Labs | SEC FORM 4 Code A | —9,795 at $0.00 | filing |
| 12 Jun 2026filed 16 Jun 2026 | CDNA CareDxDiagnostics & Labs | SEC FORM 4 Code A | —9,795 at $0.00 | filing |
| 2 Apr 2026filed 3 Apr 2026 | CDNA CareDxDiagnostics & Labs | SEC FORM 4 Code A | —1,981 at $0.00 | filing |
| 2 Apr 2026filed 3 Apr 2026 | CDNA CareDxDiagnostics & Labs | SEC FORM 4 Code A | —1,981 at $0.00 | filing |
| 31 Mar 2026filed 1 Apr 2026 | CDNA CareDxDiagnostics & Labs | SEC FORM 4 Code M | $26K5,255 at $5.02 | filing |
| 31 Mar 2026filed 1 Apr 2026 | CDNA CareDxDiagnostics & Labs | SEC FORM 4 Code M | $48K9,745 at $4.95 | filing |
| 31 Mar 2026filed 1 Apr 2026 | CDNA CareDxDiagnostics & Labs | SEC FORM 4 Code M | $14K11,500 at $1.22 | filing |
| 31 Mar 2026filed 1 Apr 2026 | CDNA CareDxoption or derivative · Diagnostics & Labs | SEC FORM 4 Code M | —5,255 at $0.00 | filing |
| 31 Mar 2026filed 1 Apr 2026 | CDNA CareDxoption or derivative · Diagnostics & Labs | SEC FORM 4 Code M | —9,745 at $0.00 | filing |
| 31 Mar 2026filed 1 Apr 2026 | CDNA CareDxoption or derivative · Diagnostics & Labs | SEC FORM 4 Code M | —11,500 at $0.00 | filing |
| 31 Mar 2026filed 1 Apr 2026 | CDNA CareDxoption or derivative · Diagnostics & Labs | SEC FORM 4 Code M | —5,255 at $0.00 | filing |
| 31 Mar 2026filed 1 Apr 2026 | CDNA CareDxoption or derivative · Diagnostics & Labs | SEC FORM 4 Code M | —9,745 at $0.00 | filing |
| 31 Mar 2026filed 1 Apr 2026 | CDNA CareDxoption or derivative · Diagnostics & Labs | SEC FORM 4 Code M | —11,500 at $0.00 | filing |
| 31 Mar 2026filed 1 Apr 2026 | CDNA CareDxDiagnostics & Labs | SEC FORM 4 Code M | $26K5,255 at $5.02 | filing |
| 31 Mar 2026filed 1 Apr 2026 | CDNA CareDxDiagnostics & Labs | SEC FORM 4 Code M | $48K9,745 at $4.95 | filing |
News
Analyzing CollPlant Biotechnologies (NASDAQ:CLGN) and CareDx (NASDAQ:CDNA)CDNA · themarketsdaily.com · 10 Oct 2026
0 headlines in the last 90 days name Michael Goldberg; 1 article from the last 14 days about the 1 company they traded most, at most three about any one of them.